Moderate riskFDA DrugClass II

Apollo Care semaglutide injection recalled for particulate matter contamination

Apollo Care's semaglutide 12.5 mg injectable medication was found to contain small particles of nylon/polyamide and silk-like material. The contamination affects multiple lots distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. If you have one of the affected lots, do not use the vial.
  2. Contact your pharmacy or healthcare provider for a replacement or guidance.
  3. Check your vial label for lot number AC-017108, AC-017110, AC-017112, AC-017142, AC-017144, AC-017166, AC-017167, AC-017177, AC-017213, AC-017224, or AC-017225.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 11 products — see all of them.

Details

Units affected
56,918 vials.
Illnesses reported
None reported
Manufactured in
3801 Mojave Ct Ste 101, Columbia, MO, United States
Classification
Class II
Recall number
D-0747-2026

In the FDA's words

Description
SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05 Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Lot: AC-017108, Exp. 11/17/2026; AC-017110, Exp. 11/20/2026; AC-017112, Exp. 11/21/2026; AC-017142, AC-017144, Exp. 12/10/2026; AC-017166, AC-017167, AC-017177, AC-017213, AC-017224, AC-017225, Exp. 12/31/2026 Distribution: Nationwide within the U.S Affected quantity: 56,918 vials.
Hazard
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

11 products in this recall

Apollo Care semaglutide vials recalled for particulate matter

Apollo Care is recalling 11 strengths of semaglutide sterile multi-dose vials for subcutaneous injection, all sold under the APOLLO care brand. The vials may contain particles identified as nylon/polyamide and silk-like material. The recall covers products distributed nationwide, and no injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug